Amexdrug Corporation (AXRX)
OTHER OTC:AXRX
US Market
Holding AXRX?
Track your performance easily

Amexdrug (AXRX) Financial Statements

23 Followers

Amexdrug Financial Overview

Amexdrug's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is 316.00; Amexdrug is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 13Mar 13Dec 12Sep 12Jun 12
Income Statement-
Total Revenue$ 2.15M$ 2.36M$ 2.48M$ 2.17M$ 2.31M
Gross Profit$ 356.76K$ 518.75K$ 150.52K$ 235.13K$ 255.93K
EBIT$ 107.64K$ 258.47K$ -86.60K$ 54.30K$ 59.22K
EBITDA$ 125.30K$ 276.16K$ -74.54K$ 56.79K$ 61.73K
Net Income Common Stockholders$ 57.88K$ 172.34K$ -100.24K$ 35.86K$ 42.33K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 168.01K$ 131.32K$ 421.95K$ 402.79K$ 107.64K
Total Assets$ 2.28M$ 2.14M$ 2.41M$ 2.18M$ 1.39M
Total Debt$ 853.09K$ 963.12K$ 1.09M$ 1.21M$ 356.84K
Net Debt$ 685.08K$ 831.80K$ 669.81K$ 803.33K$ 249.20K
Total Liabilities$ 1.63M$ 1.54M$ 1.98M$ 1.65M$ 898.60K
Stockholders Equity$ 658.23K$ 600.76K$ 429.65K$ 529.89K$ 494.03K
Cash Flow-
Free Cash Flow$ 146.60K$ -161.38K$ 33.83K$ -554.87K$ -91.66K
Operating Cash Flow$ 146.60K$ -158.98K$ 492.42K$ -554.87K$ -91.66K
Investing Cash Flow$ 427.00$ -1.14K$ -458.59K$ -1.00$ 13.00
Financing Cash Flow$ -110.43K$ -129.87K$ -15.66K$ 849.28K$ 67.32K
Currency in USD

Amexdrug Earnings and Revenue History

Amexdrug Debt to Assets

Amexdrug Cash Flow

Amexdrug Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis